Catalent | CTLT - Trade Creditors


Catalent reported $375M in Trade Creditors for its fiscal quarter ending in September of 2024.



Trade Creditors Change Date
Agilent USD 602M 32M Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Bruker USD 215.9M 31.5M Dec/2025
Centene USD 13.77B 3.1B Dec/2025
Charles River Laboratories USD 148.8M 20.82M Dec/2025
Cigna USD 10.66B 1.31B Dec/2025
Danaher USD 1.84B 147M Dec/2025
Dentsply International USD 300M 32M Dec/2025
Elevance Health USD 17.08B 64M Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Glaxosmithkline GBP 21.07B 7.42B Sep/2025
Hologic USD 201.1M 573.5M Dec/2025
Humana USD 5.72B 198M Dec/2025
Illumina USD 240M 22M Dec/2025
Intuitive Surgical USD 1.92B 179.7M Dec/2025
IQVIA Holdings USD 3.75B 201M Dec/2025
J&J USD 11.99B 2.37B Dec/2025
Laboratory Of America USD 840.8M 172.3M Dec/2025
Lonza CHF 471M 3M Dec/2024
McKesson USD 60.68B 255M Dec/2025
Merck EUR 2.11B 182M Dec/2025
Merck USD 4.15B 102M Sep/2025
Mettler Toledo International USD 266.63M 19.22M Dec/2025
Novartis USD 4.56B 49M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Quest Diagnostics USD 1.6B 143M Dec/2025
Repligen USD 30.01M 584K Dec/2025
Revvity USD 185.46M 9.66M Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
Thermo Fisher Scientific USD 3.62B 502M Dec/2025
UnitedHealth USD 40.18B 1.75B Sep/2025
Veradigm USD 12.61M 5.4M Sep/2022
Waters USD 103.78M 11.95M Dec/2025
West Pharmaceutical Services USD 253.7M 2.1M Dec/2025